1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with proadifen in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (proadifen) | Trials (proadifen) | Recent Studies (post-2010) (proadifen) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 1,481 | 0 | 35 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | proadifen (IC50) |
---|---|---|---|
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.5849 | |
Aldehyde oxidase 1 | Rattus norvegicus (Norway rat) | 1.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aepfelbacher, M; Lux, I; Weber, C; Weber, PC; Zimmer, B | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and proadifen
Article | Year |
---|---|
Docosahexaenoic acid inhibits PAF and LTD4 stimulated [Ca2+]i-increase in differentiated monocytic U937 cells.
Topics: Animals; Calcium; Cell Differentiation; Cell Line; Cytochrome P-450 Enzyme Inhibitors; Docosahexaenoic Acids; Fatty Acids, Unsaturated; Masoprocol; Monocytes; Phospholipids; Platelet Activating Factor; Proadifen; SRS-A; Tretinoin | 1991 |